Be at your best by staying as healthy as you can.
- Blog: What drug and device companies paid teaching hospitals in 2014
On June 30 the CMS posted the first full year of disclosures under the Physician Payment Sunshine Act provision of the Affordable Care Act. According to the data posted to the CMS' Open Payments website, drug and medical-device companies paid teaching hospitals $543 million in general payments, which include speaking and consulting fees, gifts, travel and royalties for drugs based on research conducted by the providers. That latter category accounts for the vast majority of payments to City of Hope, which received far more than any of its peers. City of Hope received nearly $250 million in royalties from Genentech for its work on the science underlying the cancer drugs Avastin, Rituxan and Herceptin.
Explore all of the 2014 payments to teaching hospitals disclosed by drug and device companies with the tool below.
Art Golab analyzes data and works with Modern Healthcare reporters to produce high impact stories across a range of healthcare beats. He also develops interactive online healthcare databases to provide insight to readers. A former data journalist at the Chicago Sun-Times, Golab earned a bachelor's degree in journalism from Columbia College in Chicago and an MS degree in information systems from DePaul University.Follow on Twitter